Company Overview and News
The City of Calgary is trying to spruce up the appearance of the western end of downtown by helping business owners revitalize their facades, setting aside spaces for art murals and creating temporary parks.
Canadian Pacific Railway Limited (CP - Free Report) is scheduled to report second-quarter 2018 results on Jul 18 after market close. Last reported quarter, the company came up with a negative earnings surprise of 1.4% on lower-than-expected earnings and revenues. Results were hurt by rough weather conditions. However, the top and the bottom line improved from the year-ago figures. Things do not look up for the company this to-be-reported quarter too.
CP CP UPS UNP
JACKSONVILLE, Fla., July 09, 2018 (GLOBE NEWSWIRE) -- CSX Corporation (NASDAQ:CSX) today announced that Mark Wallace has been appointed executive vice president sales and marketing and Diana Sorfleet has been appointed executive vice president and chief administrative officer.
CP CP MS.PRI MS.PRK MS.PRE MS.PRF CSX MS.PRG MS MS.PRA
Durable goods orders, a key economic indicator, are the new orders placed with domestic manufacturers for delivery of high-value factory hard goods. The US Census Bureau conducts its “Manufacturers’ Shipments, Inventories, and Orders” survey and publishes the durable goods orders data. A total of 3,000 American manufacturers from 92 different industries are surveyed for this report.
CP UNP XPO NSC AAALY BRK.A CP KSU.PR TRI AIR AAALF DAL KSU
On Jun 20, we initiated coverage on SkyWest, Inc. (SKYW - Free Report) , which operates as a regional airline in the United States through its subsidiaries — SkyWest Airlines and ExpressJet Airlines. Apart from the two scheduled passenger airline operations, SkyWest is the holding company of an aircraft leasing entity.
EXPD CP CP SKYW
It's a key piece of the city's flood mitigation puzzle — adding more than four kilometres of flood barriers in Bowness, Sunnyside, the downtown and Pearce Estate Park in Inglewood.
Shares of Canadian Pacific Railway Limited (CP - Free Report) hit a 52-week high of $194.74 during the trading session on Jun 11, before retracing a bit to close at $193.79. Notably, the stock has performed impressively in a year with a 23.8% gain, outperforming the industry’s rally of 20.4%.
GATX EXPD CP CP SKYW GMTA GMT
Dividend growth investing is a popular model followed by the investing community to build assets. Companies which not only pay dividends, but raise them year after year have been shown to perform better overall for investor returns.
LRCX CP PAG PSX KGI.DB QBCRF BMO 1128 CP AAPL CAH KL LEG WYNN KGI KGI.DB.A OTEX BMO WYNMF OTC NTAP TU QBCAF WYNMY
MONTREAL/VANCOUVER (Reuters) - In a battle to unclog rail bottlenecks that left Canadian commodities trapped in landlocked western provinces this winter, the country’s largest railways are offering C$15,000 ($11,566.93) signing bonuses for experienced workers who can hit the rails right away and get trains moving.
8h - Asif
History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...
9h - Asif
Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...
2018-07-16 - Asif
General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...
Silicon Investor Message Boards
This table lists all message boards related to TSX:CP / Canadian Pacific Railway on message board site Silicon Investor.